heart disease

A new study by WSU researchers suggests that a protein called CDK2 plays a critical role in heart damage caused by doxorubicin, a commonly used chemotherapy drug.

Using technology to help patients better self-manage their health and chronic diseases is the focus of a study by a WSU graduate and a professor of business administration.

By Will Ferguson, College of Arts & Sciences PULLMAN, Wash. – For the first time, researchers at Washington State University have created an injectable compound or “probe” that illuminates hydrogen sulfide and hydrogen polysulfides in different colors when they are present in cells.

By Linda Weiford, WSU News PULLMAN, Wash. – If you think Thanksgiving dinner can pack on the pounds, consider the grizzly bears at Washington State University that eat the equivalent of three such feasts daily during the weeks leading to hibernation. After nearly doubling their weight, they take a winter-long nap – only to wake up […]

SPOKANE, Wash. – A graduate student working in the research laboratory of a Washington State University exercise physiologist has received a second year of research funding from the American Physiological Society. Heidi Medford was one of five students nationally to have the annual grant of $28,300 renewed. Last year, she was one of eight to […]

PULLMAN – Beverages supplemented by whey-based protein can significantly reduce elevated blood pressure, reducing the risk of stroke and heart disease, a WSU study has found.   Research led by nutritional biochemist Susan Fluegel and published in the International Dairy Journal found that daily doses of commonly available whey brought a more than six-point reduction in […]

Heart disease is the number 1 cause of death (more women than men), and stroke is number 3. The WSU community has a chance to take a step against them — several “steps,” in fact. The Spokane American Heart Walk takes place April 19 at Riverfront Park, with a 1-mile or 3-mile course. WSU Spokane […]